Rheumatic Diseases: Clinical Trials

10,935 trials for Rheumatic Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6391 completed, 1685 unknown, 972 recruiting, 644 terminated. 4312 Not applicable, 1426 Phase 2, 1194 Phase 3, 898 Phase 4, 822 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable4312Completed 2402, Unknown 742, Recruiting 432, Not yet recruiting 228, Active not recruiting 192, Terminated 167, Withdrawn 93, Enrolling by invitation 39, Suspended 17
Phase 21426Completed 910, Unknown 151, Terminated 148, Recruiting 86, Withdrawn 57, Not yet recruiting 36, Active not recruiting 27, Enrolling by invitation 7, Suspended 4
Phase 31194Completed 861, Unknown 108, Terminated 87, Recruiting 54, Active not recruiting 34, Withdrawn 25, Not yet recruiting 18, Enrolling by invitation 6, Suspended 1
Phase 4898Completed 541, Unknown 149, Terminated 83, Recruiting 54, Not yet recruiting 30, Withdrawn 29, Active not recruiting 10, Enrolling by invitation 2
Phase 1822Completed 523, Unknown 100, Recruiting 75, Terminated 44, Withdrawn 33, Active not recruiting 23, Not yet recruiting 19, Enrolling by invitation 3, Suspended 2
Early Phase 186Completed 27, Unknown 20, Recruiting 17, Not yet recruiting 10, Withdrawn 5, Active not recruiting 3, Suspended 2, Enrolling by invitation 1, Terminated 1

Follow Rheumatic Diseases: new trials by email Literature Review of Rheumatic Diseases trials Research Report on Rheumatic Diseases

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of AQUACEL™ Ag Surgical Cover Dressing Following Total Knee Replacement
Aquacel Ag dressing - Osteoarthritis
Not applicableWithdrawnGolden Jubilee National Hospital2050-01-012019-07-31
Cannabichromene Safety in Rheumatoid Arthritis
Cannabichromene - Arthritis, Rheumatoid
Phase 1 / Phase 2WithdrawnCrystal Lederhos Smith2028-07-152026-09-23
An Open-label Study of GC012F in Rheumatoid Arthritis.
LD and GC012F CAR-T Cell Injection, GC012F CAR-T Cell Injection - Rheumatoid Arthritis
Early Phase 1WithdrawnInstitute of Hematology & Blood Diseases Hospital, China2027-12-012026-06-10
Evaluating the Effect of Adipose Tissue Processed With the SyntrFuge™ System for Knee Osteoarthritis
SyntrFuge System, Triamcinolone Injection - Knee Osteoarthritis
Not applicableNot yet recruitingSyntr Health Technologies, Inc.1802027-12-012026-08-20
Clinical Outcomes of Focused Shockwave Therapy Without Adjunct Rehabilitation Compared to Standard Physical Rehabilitation in Patients With Grade I-III Knee Osteoarthritis: A Single-Blind Randomized Study
Physical Rehab, Focused Shockwave Therapy - Knee Osteoarthristis
Not applicableNot yet recruitingPulse Wave USA602027-09-252026-05-05
Efficacy and Safety of GNSC-001 Intra-articular Injection for Knee Osteoarthritis
Gene Therapy GNSC-001, Placebo - Knee Arthritis Osteoarthritis, Knee Arthritis, Osteoarthritis
Phase 2 / Phase 3Not yet recruitingGenascence Corporation2402027-07-012026-09-21
Feasibility and Preliminary Effects of an Asynchronous Microlearning Intervention on Fibromyalgia Knowledge Among Primary Health Care Workers
Written Educational Material on Fibromyalgia, Asynchronous Microlearning Intervention on Fibromyalgia - Fibromyalgia, Fibromyalgia (FM)
Not applicableNot yet recruitingInstituto Neurociencia Del Dolor682027-06-012026-10-13
Duloxetine and aeRobic Exercise to Improve Function in VEterans With Knee Osteoarthritis (DRIVE)
Exercise, Duloxetine, Placebo - Knee Osteoarthritis, Pain
Phase 2Not yet recruitingVA Office of Research and Development1022027-03-012026-06-16
Undenatured Type II Collagen for Knee Osteoarthritis Pain
Placebo, Nuvicol II, Nuvicol SII - Osteoarthritis, Knee
Not applicableRecruitingUniversidad Católica San Antonio de Murcia1202027-03-012026-10-22
Comparing Pain Science Education to Biomedical Education for People With Knee Osteoarthritis: A Randomized Controlled Trial
Pain Science Education, Biomedical Education - Knee Arthritis Osteoarthritis
Not applicableNot yet recruitingMcMaster University822027-02-012026-09-16
Improving Management and Secondary Prevention Through Azithromycin Comparative Trial in Rheumatic Heart Disease in Nigeria)- IMPACT-RHD Nigeria
Benzathine Penicillin, Azithromycin (Azithro) - Rheumatic Fever, Valvular Heart Diseases
Not applicableNot yet recruitingLadoke Akintola University of Technology, Ogbomoso, Nigeria4742027-01-052026-06-04
AI and Computer Vision-Assisted Telerehabilitation in Fibromyalgia: The FibroIA 2.0 Trial
AI Combined (mobility and resistance training), AI mobility - Fibromyalgia, Fibromyalgia (FM)
Not applicableNot yet recruitingInstituto Neurociencia Del Dolor662027-01-042026-07-01
Treatment of Fibromyalgia and PTSD With Live and Inactive Vagus Nerve Stimulation With PEPC
tAN plus PEPC, sham plus PEPC - Fibromyalgia (FM), Posttraumatic Stress Disorder (PTSD)
Not applicableNot yet recruitingVA Office of Research and Development1802027-01-012026-09-29
HTO and Tranexamic Acid Study
Tranexamic Acid, Routine medial opening wedge high tibial osteotomy - Osteoarthritis, Knee
Phase 3Not yet recruitingWestern University, Canada2002027-01-012026-09-17
FIBROmyalgia: Somatic Tracking and Exercise Program Study
Group exercising, Somatic tracking, General activity recommendaitons - Fibromyalgia (FM), Fibromyalgia
Not applicableNot yet recruitingUniversity of Tromso2002027-01-012025-05-13
Zynrelef Versus Adductor Canal Block
ZYNRELEF 400Mg-12Mg Extended-Release Solution, Ultrasound-Guided Adductor Canal Block, Ropivacaine 0.5% Injectable Solution - Knee Osteoarthritis, Arthritis Knee
Phase 4Not yet recruitingUniversity of Miami1202027-01-012026-06-12
Patient-Reported Outcomes Dashboard With Goal Setting to Support Shared Decision-Making in Inflammatory Arthritis
Patient-Reported Outcomes Dashboard With Goal Setting - Arthritis, Psoriatic (PsA), Arthritis, Rheumatoid (RA)
Not applicableNot yet recruitingNorthwestern University1602027-01-012026-10-15
Pilot and Feasibility Study of Anti-CD14 for the Treatment of Knee Osteoarthritis
Atibuclimab, saline placebo - Knee Osteoarthritis (Knee OA)
Phase 1Not yet recruitingVA Office of Research and Development402027-01-012026-07-15
Penn SICCA Follow-up Study
Dry Eye, Sjogren's Syndrome
Not yet recruitingUniversity of Pennsylvania2202027-01-012026-03-02
Heart Rate Variability Guided Physical Activity and Exercise Prescription in Individuals With Knee Osteoarthritis
HRV-guided home exercise prescription, Traditional Home Exercise - Knee Osteoarthritis
Not applicableNot yet recruitingThe Hong Kong Polytechnic University2402027-01-012026-02-12

Showing 20 of 10935. Sign in to see all of them.

Narrower conditions

Arthritis, Rheumatoid (3278)  ·  Osteoarthritis, Knee (3209)  ·  Osteoarthritis (2690)  ·  Fibromyalgia (1230)  ·  Pain (727)  ·  Osteoarthritis, Hip (634)  ·  Arthritis (483)  ·  Motor Activity (370)  ·  Arthritis, Juvenile (356)  ·  Chronic Pain (346)  ·  Sjogren's Syndrome (318)  ·  Gout (307)  ·  Joint Diseases (223)  ·  Arthritis, Psoriatic (193)

Broader conditions

Musculoskeletal Diseases (10807)  ·  Joint Diseases (9401)  ·  Arthritis (9121)  ·  Skin and Connective Tissue Diseases (4207)  ·  Connective Tissue Diseases (4151)  ·  Immune System Diseases (3956)  ·  Autoimmune Diseases (3808)  ·  Osteoarthritis (2931)  ·  Pathological Conditions, Signs and Symptoms (2197)  ·  Nervous System Diseases (1641)  ·  Signs and Symptoms (1592)  ·  Muscular Diseases (1443)  ·  Neurologic Manifestations (1395)  ·  Neuromuscular Diseases (1376)

Interventions

Methotrexate (314)  ·  Exercise (220)  ·  tocilizumab (193)  ·  Adalimumab (171)  ·  Etanercept (154)  ·  Sodium Chloride (133)  ·  Arthroplasty, Replacement, Knee (127)  ·  Abatacept (100)  ·  Rituximab (96)  ·  Infliximab (93)  ·  Hyaluronic Acid (92)  ·  tofacitinib (83)  ·  Arthroplasty, Replacement, Hip (82)  ·  Saline Solution (78)  ·  Celecoxib (71)

Sponsors

Hoffmann-La Roche (199)  ·  Pfizer (181)  ·  Zimmer Biomet (124)  ·  Bristol-Myers Squibb (96)  ·  Assiut University (87)  ·  Amgen (81)  ·  Riphah International University (80)  ·  Novartis Pharmaceuticals (73)  ·  Eli Lilly and Company (67)  ·  Assistance Publique - Hôpitaux de Paris (64)  ·  Istituto Ortopedico Rizzoli (60)  ·  GlaxoSmithKline (58)  ·  AbbVie (56)  ·  Cairo University (53)  ·  AstraZeneca (50)

Countries

United States (3113)  ·  France (775)  ·  Turkey (Türkiye) (729)  ·  Canada (719)  ·  Spain (654)  ·  United Kingdom (651)  ·  Germany (641)  ·  China (566)  ·  Poland (507)  ·  Italy (493)  ·  South Korea (378)  ·  Denmark (366)  ·  Brazil (356)  ·  Belgium (340)  ·  Australia (315)

Results publications

PMID 36600185, PMID 36601090, PMID 36931693, PMID 36526796, PMID 32816215, PMID 33127856, PMID 34870800, PMID 28143815, PMID 39192350, PMID 25047021, PMID 27338778, PMID 38958913, PMID 29244149, PMID 30649524, PMID 37453736, PMID 26275429, PMID 30936738, PMID 33263165, PMID 34706874, PMID 37460782, PMID 29463520, PMID 34041702, PMID 31610021, PMID 36205910, PMID 37747626, PMID 20461783, PMID 28941219, PMID 30177460, PMID 35577477, PMID 36715850, PMID 36754548, PMID 36814062, PMID 37308218, PMID 37945286, PMID 37982966, PMID 40875187, PMID 41766528, PMID 21055873, PMID 22491018, PMID 26554876, PMID 27889300, PMID 29949132, PMID 30219772, PMID 30842122, PMID 33057725, PMID 33059710, PMID 33115760, PMID 34921355, PMID 36125701, PMID 36269595

NIH funding

2009 (49), 2015 (41), 2016 (35), 2014 (34), 2023 (31), 2017 (28), 2008 (27), 2025 (26), 2018 (25), 2019 (21), 2005 (12), 2004 (6), P60AR047782 (3), R01AT004623 (3), K23AG029978 (2)